Finland Neurology Devices Market Analysis Report 2022-30

Finland Neurology Devices Market Analysis

$ 3999

The Finland Neurology Device Market is expected to grow from $27 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for 2022-2030. The demand for neurology devices, such as neurostimulation devices, EEG machines, and imaging systems, rises in tandem with the prevalence of neurological illnesses. The elderly population in Finland is increasing, and this group is more likely to experience neurological diseases. Manufacturers can take advantage of this potential by creating neurological Devices that meet the demands of patients. The market is segmented by product type and by the end user. Some key players in the market include Johnson and Johnson, GE Healthcare, Stryker and Medtronic.

ID: IN10FIMD012 CATEGORY: Medical Devices GEOGRAPHY: Finland AUTHOR: Jigyasu Bhandari

Buy Now

Finland Neurology Devices Market Executive Analysis

The Finland Neurology Devices Market size is around $27 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. Finland spent $24.0 billion on healthcare in 2020, an increase of 3.0% in real terms from the previous year. A $4000 per capita cost was incurred. Healthcare costs made up 9.2% of the GDP in 2020, an increase of 0.2% points over the previous two years. In 2021, governmental funding comprised 78.54% of health spending, while private money comprised 24% of it. From 2018, the proportion of public funding increased by 0.8%.

In Finland, there are roughly 13,000 new cases of stroke each year, and there are about 110,000 persons who have had a stroke. In Finland, there are thought to be 15,000 to 20,000 people who have Parkinson's disease. Around 7,000 to 8,000 people in Finland are thought to have Multiple Sclerosis (MS) on average. In Finland, there are currently 200,000 persons who have Alzheimer's disease or another type of dementia. There are roughly 50,000 people in Finland who have epilepsy. Patients recovering from neurological disorders like spinal cord injuries and stroke use neurology devices, such as robotic exoskeletons and virtual reality systems. In order to treat neurological conditions such as chronic pain, mobility problems, and spasticity, neurology devices are used.

Finland Neurology Device Market Analysis

Market Dynamics

Market Growth Drivers

The elderly population in Finland is increasing, and this group is more likely to experience neurological diseases. Manufacturers can take advantage of this potential by creating neurological Devices that meet the demands of senior patients. The demand for neurology devices, such as neurostimulation devices, EEG machines, and imaging systems, rises in tandem with the prevalence of neurological illnesses. Manufacturers can take advantage of this chance by creating cutting-edge neurology devices that are tailored to the individual requirements of patients and healthcare professionals. Technical developments in neurology devices have led to the creation of ground-breaking devices with enhanced therapeutic and diagnostic capabilities. Manufacturers can take advantage of this chance by spending money on research and development to build cutting-edge neurology devices that provide more precision, sensitivity, and patient comfort.

Market Restraints

In Finland, there is government oversight of neurology devices, and following the rules can be significant and time-consuming. Maintaining compliance with evolving regulatory requirements, particularly for more modern and complicated devices, may be difficult for manufacturers in Finland.

Competitive Landscape

Key Players

Stryker
Medtronic
Johnson & Johnson
Penumbra
Natus Medical
GE Healthcare

Recent Notable Deals

2021: In 2021, the Swiss firm Abacus Medical and the Finland Company Nexstim signed a distribution agreement to offer Nexstim's NBS System throughout the Nordic and Baltic nations. Nexstim develops and markets guided brain stimulation systems for therapeutic and diagnostic uses.

2021: In 2021, Kapyla Rehabilitation Center, a Finnish neurological rehabilitation centre, and the Finnish business Kaiku Health, which offers digital patient monitoring and patient-reported outcome solutions, partnered to create a digital platform for monitoring patients with neurological illnesses.

Healthcare Policies and Regulatory Landscape

In Finland, The National Supervisory Authority for Welfare and Health and the Finnish Medicines Agency (FIMEA) are in authority of the regulatory environment for neurology devices. The Finland government also encourages the use of cutting-edge medical technologies, including neurology devices, through a number of programmes like the Innovative Public Procurement programme. This programme promotes the use of cutting-edge medical technologies by public healthcare providers, such as neurology devices, through open public procurement procedures.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.